Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: How close are we?

Trends in Molecular Medicine

Volumn 12, Issue 3, 2006, Pages 122-129

  Miura, Pedro ^a   Jasmin, Bernard J ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ARGININE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCINEURIN; CORTICOSTEROID; CYCLOSPORIN; DEFLAZACORT; DYSTROPHIN; HISTONE DEACETYLASE INHIBITOR; MOLSIDOMINE; NEU DIFFERENTIATION FACTOR; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PREDNISONE; SALBUTAMOL; TRANSCRIPTION FACTOR NFAT; UTROPHIN;

BECKER MUSCULAR DYSTROPHY; BEHAVIOR DISORDER; BIOLOGICAL MODEL; CLINICAL PATHWAY; CLINICAL STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG SCREENING; DUCHENNE MUSCULAR DYSTROPHY; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIDE EFFECT; SLOW MUSCLE FIBER; SYMPTOMATOLOGY; TRANSCRIPTION INITIATION; UPREGULATION; WEIGHT GAIN;

ANIMALS; CALCINEURIN; DYSTROPHIN; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NEUREGULIN-1; NFATC TRANSCRIPTION FACTORS; NITRIC OXIDE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION; UTROPHIN;

ANIMALIA;

EID: 33644975603     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.01.002     Document Type: Review

References (82)

1. A.E. Emery Population frequencies of inherited neuromuscular diseases - a world survey Neuromuscul. Disord. 1 1991 19 29
2. R.G. Worton, and M.W. Thompson Genetics of Duchenne muscular dystrophy Annu. Rev. Genet. 22 1988 601 629
3. I. Dalkilic, and L.M. Kunkel Muscular dystrophies: genes to pathogenesis Curr. Opin. Genet. Dev. 13 2003 231 238
4. D.J. Blake Function and genetics of dystrophin and dystrophin-related proteins in muscle Physiol. Rev. 82 2002 291 329
5. K.A. Lapidos The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma Circ. Res. 94 2004 1023 1031
6. R.D. Cohn, and K.P. Campbell Molecular basis of muscular dystrophies Muscle Nerve 23 2000 1456 1471
7. T.A. Rando The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies Muscle Nerve 24 2001 1575 1594
8. J.E. Brenman Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy Cell 82 1995 743 752
9. B. Yang SH3 domain-mediated interaction of dystroglycan and Grb2 J. Biol. Chem. 270 1995 11711 11714
10. R. Madhavan Calmodulin specifically binds three proteins of the dystrophin-glycoprotein complex Biochem. Biophys. Res. Commun. 185 1992 753 759
11. P. Gregorevic Systemic delivery of genes to striated muscles using adeno-associated viral vectors Nat. Med. 10 2004 828 834
12. A. Goyenvalle Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping Science 306 2004 1796 1799
13. E. Bachrach Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 3581 3586
14. K.J. Nowak, and K.E. Davies Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment EMBO Rep. 5 2004 872 876
15. J.V. Chakkalakal Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies FASEB J. 19 2005 880 891
16. E.R. Barton-Davis Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice J. Clin. Invest. 104 1999 375 381
17. J.G. Tidball, and M. Wehling-Henricks Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events Pediatr. Res. 56 2004 831 841
18. S. Bogdanovich Functional improvement of dystrophic muscle by myostatin blockade Nature 420 2002 418 421
19. E.G. Fowler Pilot trial of albuterol in Duchenne and Becker muscular dystrophy Neurology 62 2004 1006 1008
20. B.J. Jasmin Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers: insights into a therapeutic strategy for Duchenne muscular dystrophy J. Physiol. (Paris) 96 2002 31 42
21. T.S. Khurana, and K.E. Davies Pharmacological strategies for muscular dystrophy Nat. Rev. Drug Discov. 2 2003 379 390
22. K.J. Perkins, and K.E. Davies The role of utrophin in the potential therapy of Duchenne muscular dystrophy Neuromuscul. Disord. 12 Suppl. 1 2002 S78 S89
23. J.M. Tinsley Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene Nature 384 1996 349 353
24. R. Gilbert Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles Hum. Gene Ther. 10 1999 1299 1310
25. S. Ebihara Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice Physiol. Genomics 3 2000 133 144
26. R. Fisher Non-toxic ubiquitous over-expression of utrophin in the mdx mouse Neuromuscul. Disord. 11 2001 713 721
27. L. Politano Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results Acta Myol. 22 2003 15 21
28. T.S. Khurana Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle Neuromuscul. Disord. 1 1991 185 194
29. K. Ohlendieck Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle Neuron 7 1991 499 508
30. A. Clerk Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle Histochem. J. 25 1993 554 561
31. S. Lin, and J.M. Burgunder Utrophin may be a precursor of dystrophin during skeletal muscle development Brain Res. Dev. Brain Res. 119 2000 289 295
32. N.F. Olivieri, and D.J. Weatherall The therapeutic reactivation of fetal haemoglobin Hum. Mol. Genet. 7 1998 1655 1658
33. A.P. Weir A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle J. Biol. Chem. 277 2002 45285 45290
34. J.V. Chakkalakal Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling Proc. Natl. Acad. Sci. U. S. A. 100 2003 7791 7796
35. C.L. Dennis Molecular and functional analysis of the utrophin promoter Nucleic Acids Res. 24 1996 1646 1652
36. P.J. Schaeffer Calcineurin and calcium/calmodulin-dependent protein kinase activate distinct metabolic gene regulatory programs in cardiac muscle J. Biol. Chem. 279 2004 39593 39603
37. A.O. Gramolini Local transcriptional control of utrophin expression at the neuromuscular synapse J. Biol. Chem. 272 1997 8117 8120
38. A.O. Gramolini Muscle and neural isoforms of agrin increase utrophin expression in cultured myotubes via a transcriptional regulatory mechanism J. Biol. Chem. 273 1998 736 743
39. T.S. Khurana Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein α/β Mol. Biol. Cell 10 1999 2075 2086
40. A.O. Gramolini Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein Proc. Natl. Acad. Sci. U. S. A. 96 1999 3223 3227
41. F. Galvagni Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter J. Mol. Biol. 306 2001 985 996
42. M. Gyrd-Hansen Sp1 and the ets-related transcription factor complex GABP α/β functionally cooperate to activate the utrophin promoter J. Neurol. Sci. 197 2002 27 35
43. M. Rodova Okadaic acid augments utrophin in myogenic cells Neurosci. Lett. 363 2004 163 167
44. L.M. Angus Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1α, drives utrophin gene expression at the neuromuscular junction Am. J. Physiol. Cell Physiol. 289 2005 C908 C917
45. J. Lin Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres Nature 418 2002 797 801
46. C. Webster Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy Cell 52 1988 503 513
47. P. Moens Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch J. Muscle Res. Cell Motil. 14 1993 446 451
48. A.O. Gramolini Increased expression of utrophin in a slow versus a fast muscle involves posttranscriptional events Am. J. Physiol. Cell Physiol. 281 2001 C1300 C1309
49. E.N. Olson, and R.S. Williams Calcineurin signaling and muscle remodeling Cell 101 2000 689 692
50. A. Briguet Transcriptional activation of the utrophin promoter B by a constitutively active Ets-transcription factor Neuromuscul. Disord. 13 2003 143 150
51. M.A. Stocksley A 1.3kb promoter fragment confers spatial and temporal expression of utrophin A mRNA in mouse skeletal muscle fibers Neuromuscul. Disord. 15 2005 437 449
52. T.O. Krag Heregulin ameliorates the dystrophic phenotype in mdx mice Proc. Natl. Acad. Sci. U. S. A. 101 2004 13856 13860
53. J. Tinsley Expression of full-length utrophin prevents muscular dystrophy in mdx mice Nat. Med. 4 1998 1441 1444
54. J.V. Chakkalakal Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice Hum. Mol. Genet. 13 2004 379 388
55. J.D. Molkentin A calcineurin-dependent transcriptional pathway for cardiac hypertrophy Cell 93 1998 215 228
56. J. Finsterer, and C. Stollberger The heart in human dystrophinopathies Cardiology 99 2003 1 19
57. M.D. Bonifati A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy Muscle Nerve 23 2000 1344 1347
58. S.J. St Pierre Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin-NF-AT pathway FASEB J. 18 2004 1937 1939
59. A. De Luca A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice Am. J. Pathol. 166 2005 477 489
60. I. Fisher Prednisolone-induced changes in dystrophic skeletal muscle FASEB J. 19 2005 834 836
61. J.S. Stamler, and G. Meissner Physiology of nitric oxide in skeletal muscle Physiol. Rev. 81 2001 209 237
62. M. Wehling A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice J. Cell Biol. 155 2001 123 131
63. E. Chaubourt Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy Neurobiol. Dis. 6 1999 499 507
64. E.R. Barton Systemic administration of l-arginine benefits mdx skeletal muscle function Muscle Nerve 32 2005 751 760
65. V. Voisin l-Arginine improves dystrophic phenotype in mdx mice Neurobiol. Dis. 20 2005 123 130
66. I. Waheed Factors associated with induced chronic inflammation in mdx skeletal muscle cause posttranslational stabilization and augmentation of extrasynaptic sarcolemmal utrophin Hum. Gene Ther. 16 2005 489 501
67. H.X. Nguyen, and J.G. Tidball Expression of a muscle-specific, nitric oxide synthase transgene prevents muscle membrane injury and reduces muscle inflammation during modified muscle use in mice J. Physiol. 550 2003 347 356
68. M. Sander Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy Proc. Natl. Acad. Sci. U. S. A. 97 2000 13818 13823
69. R. Tatsumi Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide Mol. Biol. Cell 13 2002 2909 2918
70. N.E. Hynes, and H.A. Lane ERBB receptors and cancer: the complexity of targeted inhibitors Nat. Rev. Cancer 5 2005 341 354
71. T.A. McKinsey, and E.N. Olson Toward transcriptional therapies for the failing heart: chemical screens to modulate genes J. Clin. Invest. 115 2005 538 546
72. C. Handschin An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle Proc. Natl. Acad. Sci. U. S. A. 100 2003 7111 7116
73. T.A. McKinsey MEF2: a calcium-dependent regulator of cell division, differentiation and death Trends Biochem. Sci. 27 2002 40 47
74. T.A. McKinsey Control of muscle development by dueling HATs and HDACs Curr. Opin. Genet. Dev. 11 2001 497 504
75. R.R. Rosato, and S. Grant Histone deacetylase inhibitors in cancer therapy Cancer Biol. Ther. 2 2003 30 37
76. B. Staels, and J.C. Fruchart Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 54 2005 2460 2470
77. Y.X. Wang Regulation of muscle fiber type and running endurance by PPARδ PLoS Biol. 2 2004 e294
78. A.O. Gramolini Distinct regions in the 3′ untranslated region are responsible for targeting and stabilizing utrophin transcripts in skeletal muscle cells J. Cell Biol. 154 2001 1173 1183
79. P. Miura The utrophin A 5′-untranslated region confers internal ribosome entry site-mediated translational control during regeneration of skeletal muscle fibers J. Biol. Chem. 280 2005 32997 33005
80. A. Bonet-Kerrache The GTPase RhoA increases utrophin expression and stability, as well as its localization at the plasma membrane Biochem. J. 391 2005 261 268
81. K. Fujimori Interleukin 6 induces overexpression of the sarcolemmal utrophin in neonatal mdx skeletal muscle Hum. Gene Ther. 13 2002 509 518
82. M. Cerletti Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer Gene Ther. 10 2003 750 757